CIP
CLVS

Chartwell Investment Partners’s Clovis Oncology, Inc. CLVS Stock Holding History

Chartwell Investment Partners’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-51,377
Closed -$3.49M – 433
2017
Q4 		$3.49M Sell
51,377
-13,736
-21% -$960K 0.12% 258
2017
Q3 		$5.37M Buy
65,113
+16,950
+35% +$1.34M 0.18% 181
2017
Q2 		$4.51M Buy
48,163
+21,063
+78% +$1.29M 0.17% 176
2017
Q1 		$1.73M Buy
+27,100
New +$1.65M 0.06% 302

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Chartwell Investment Partners's CLVS Position: Q1 2018 in Review

Chartwell Investment Partners sold out of Clovis Oncology, Inc. (CLVS) in Q1 2018, closing a stake of 51,377 shares — an estimated $3.49M sold.

Chartwell Investment Partners first reported a position in CLVS in Q1 2017 and held it in 4 quarters. The position peaked at $5.37M in Q3 2017. 229 funds tracked by Wall St. Rank hold CLVS as of Q1 2018.

  • Chartwell Investment Partners reported no remaining Clovis Oncology, Inc. position as of Q1 2018 after selling out during the quarter.
  • Chartwell Investment Partners sold 51,377 Clovis Oncology, Inc. shares in Q1 2018, an estimated $3.49M.
  • Chartwell Investment Partners first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 4 quarters.
  • Chartwell Investment Partners's Clovis Oncology, Inc. position peaked at $5.37M in Q3 2017.
  • 229 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2018.

Based on Chartwell Investment Partners's 13F filing for Q1 2018, filed 8 May 2018.